PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting

Poly(ADP-ribose) polymerases have shown true promise in early clinical studies due to reported activity in BRCA-associated cancers. PARP inhibitors may represent a potentially important new class of chemotherapeutic agents directed at targeting cancers with defective DNA-damage repair. In order to w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziadkowiec, Karolina N., Gąsiorowska, Emilia, Nowak-Markwitz, Ewa, Jankowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327624/
https://www.ncbi.nlm.nih.gov/pubmed/28250726
http://dx.doi.org/10.5114/pm.2016.65667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327624/
https://www.ncbi.nlm.nih.gov/pubmed/28250726
http://dx.doi.org/10.5114/pm.2016.65667

Ejemplares similares